Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biovie (BIVI) Income towards Parent Company: 2017-2025

Historic Income towards Parent Company for Biovie (BIVI) over the last 7 years, with Jun 2025 value amounting to -$3.5 million.

  • Biovie's Income towards Parent Company rose 29.38% to -$3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$17.9 million, marking a year-over-year increase of 45.73%. This contributed to the annual value of -$17.9 million for FY2025, which is 45.73% up from last year.
  • As of Q2 2025, Biovie's Income towards Parent Company stood at -$3.5 million, which was down 25.13% from -$2.8 million recorded in Q1 2025.
  • In the past 5 years, Biovie's Income towards Parent Company registered a high of -$2.8 million during Q1 2025, and its lowest value of -$131.5 million during Q2 2021.
  • Moreover, its 3-year median value for Income towards Parent Company was -$7.8 million (2023), whereas its average is -$7.5 million.
  • In the last 5 years, Biovie's Income towards Parent Company crashed by 716.83% in 2021 and then soared by 93.85% in 2022.
  • Biovie's Income towards Parent Company (Quarterly) stood at -$5.4 million in 2021, then crashed by 189.73% to -$15.7 million in 2022, then spiked by 46.44% to -$8.4 million in 2023, then increased by 14.81% to -$7.2 million in 2024, then climbed by 29.38% to -$3.5 million in 2025.
  • Its Income towards Parent Company was -$3.5 million in Q2 2025, compared to -$2.8 million in Q1 2025 and -$7.2 million in Q4 2024.